Items where Author is "Dettling, Steffen"

Article

Ge, Yingzi and Boehm, Hans-Henning and Rathinasamy, Anchana and Xydia, Maria and Hu, Xiaoying and Pincha, Mudita and Umansky, Ludmila and Breyer, Christopher and Hillier, Michael and Bonertz, Andreas and Sevko, Alexandra and Domschke, Christoph and Schuetz, Florian and Frebel, Helge and Dettling, Steffen and Herold-Mende, Christel and Reissfelder, Christoph and Weitz, Juergen and Umansky, Viktor and Beckhove, Philipp (2019) Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer. CANCER IMMUNOLOGY RESEARCH, 7 (12). pp. 1998-2012. ISSN 2326-6066, 2326-6074

Dettling, Steffen and Stamova, Slava and Warta, Rolf and Schnoelzer, Martina and Rapp, Carmen and Rathinasamy, Anchana and Reuss, David and Pocha, Kolja and Roesch, Saskia and Jungk, Christine and Warnken, Uwe and Eckstein, Volker and Grabe, Niels and Schramm, Christoph and Weigand, Markus A. and von Deimling, Andreas and Unterberg, Andreas and Beckhove, Philipp and Herold-Mende, Christel (2018) Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma. CLINICAL CANCER RESEARCH, 24 (12). pp. 2951-2962. ISSN 1078-0432, 1557-3265

Rathinasamy, Anchana and Domschke, Christoph and Ge, Yingzi and Boehm, Hans-Henning and Dettling, Steffen and Jansen, David and Lasitschka, Felix and Umansky, Ludmila and Graeler, Markus H. and Hartmann, Jennifer and Herold-Mende, Christel and Schuetz, Florian and Beckhove, Philipp (2017) Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1. CANCER IMMUNOLOGY IMMUNOTHERAPY, 66 (5). pp. 593-603. ISSN 0340-7004, 1432-0851

Other

Rathinasamy, Anchana and Boehm, Hans-Henning and Ge, Yingzi and Dettling, Steffen and Umansky, Ludmila and Domschke, Christoph and Herold-Mende, Christel and Schuetz, Florian and Beckhove, Philipp (2016) Tumor antigen specific Treg from the bone marrow migrate towards increased S1P and CCL2 gradients established in the blood of breast cancer patients. AMER ASSOC IMMUNOLOGISTS, BETHESDA.